Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JT001 (NLRP3-IN-19) is a potent, specific, and orally active NLRP3 inhibitor that impedes the assembly of the NLRP3 inflammasome. This action results in the suppression of cytokine release and prevention of pyroptosis. JT001 is utilized in research on nonalcoholic steatohepatitis and liver fibrosis [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | JT001 (NLRP3-IN-19) is a potent, specific, and orally active NLRP3 inhibitor that impedes the assembly of the NLRP3 inflammasome. This action results in the suppression of cytokine release and prevention of pyroptosis. JT001 is utilized in research on nonalcoholic steatohepatitis and liver fibrosis [1]. |
別名 | NLRP3-IN-19 |
分子量 | 402.47 |
分子式 | C19H22N4O4S |
CAS No. | 2238819-65-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NLRP3-IN-19 2238819-65-1 Immunology/Inflammation NOD-like Receptor (NLR) Inhibitor inhibitor inhibit